Symmetry Partners’s ICU Medical ICUI Stock Holding History

Symmetry Partners’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-699	Closed	-$167K	–	374
2019 Q1	$167K	Hold	699	–	–	0.03%	334
2018 Q4	$161K	Buy	+699	New	+$172K	0.04%	277

Other funds holding ICUI

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Symmetry Partners's ICUI Position: Q2 2019 in Review

Symmetry Partners sold out of ICU Medical (ICUI) in Q2 2019, closing a stake of 699 shares — an estimated $167K sold.

Symmetry Partners first reported a position in ICUI in Q4 2018 and held it in 2 quarters. The position peaked at $167K in Q1 2019. 270 funds tracked by Wall St. Rank hold ICUI as of Q2 2019.

Symmetry Partners reported no remaining ICU Medical position as of Q2 2019 after selling out during the quarter.
Symmetry Partners sold 699 ICU Medical shares in Q2 2019, an estimated $167K.
Symmetry Partners first reported a position in ICU Medical in Q4 2018 and held it in 2 quarters.
Symmetry Partners's ICU Medical position peaked at $167K in Q1 2019.
270 funds tracked by Wall St. Rank held ICU Medical as of Q2 2019.

Based on Symmetry Partners's 13F filing for Q2 2019, filed 7 Aug 2019.